HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr |
What is the latest Revenue of HIKAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹2,023 Cr |
| Mar2023 | ₹1,943 Cr |
| Mar2022 | ₹1,720 Cr |
| Mar2021 | ₹1,507 Cr |
How is Revenue of HIKAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -11.79 | |
| Mar2024 | ₹2,023 Cr | 4.13 | |
| Mar2023 | ₹1,943 Cr | 12.92 | |
| Mar2022 | ₹1,720 Cr | 14.14 | |
| Mar2021 | ₹1,507 Cr | - | |
Compare Revenue of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,419.1 Cr | 1.7% | -12.9% | -43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 1.7% |
-12.9% |
-43.7% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses